{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:14:15Z","timestamp":1770524055793,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellsig.2023.110871","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T11:42:33Z","timestamp":1693309353000},"page":"110871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Signal sequence receptor subunit 3: A novel indicator of immunosuppressive tumor microenvironment and clinical benefits from immunotherapy"],"prefix":"10.1016","volume":"111","author":[{"given":"Qin","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gujie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2023.110871_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2020.03.016","article-title":"Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma","volume":"479","author":"Zhang","year":"2020","journal-title":"Cancer Lett."},{"issue":"7471","key":"10.1016\/j.cellsig.2023.110871_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellsig.2023.110871_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2023.110871_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/608406","article-title":"Immune microenvironment in tumor progression: characteristics and challenges for therapy","volume":"2012","author":"Chew","year":"2012","journal-title":"J. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110871_bb0035","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.biocel.2013.04.026","article-title":"The orphan nuclear receptor TR3\/Nur77 regulates ER stress and induces apoptosis via interaction with TRAPgamma","volume":"45","author":"Chen","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110871_bb0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jcb.20794","article-title":"Molecular regulation of androgen action in prostate cancer","volume":"99","author":"Dehm","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110871_bb0045","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1007\/s13277-016-5227-3","article-title":"Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110871_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/cmb.2018.0143","article-title":"Measuring DNA copy number variation using high-density methylation microarrays","volume":"26","author":"Cho","year":"2019","journal-title":"J. Comput. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12881-019-0909-5","article-title":"Copy number variation is highly correlated with differential gene expression: a pan-cancer study","volume":"20","author":"Shao","year":"2019","journal-title":"BMC Med. Genet."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110871_bb0060","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110871_bb0065","first-page":"197","article-title":"Segregation of the signal sequence receptor protein in the rough endoplasmic reticulum membrane","volume":"53","author":"Vogel","year":"1990","journal-title":"Eur. J. Cell Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110871_bb0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1083\/jcb.200711107","article-title":"The expanding role of the ER translocon in membrane protein folding","volume":"179","author":"Skach","year":"2007","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110871_bb0075","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-017-2743-2","article-title":"Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agents","volume":"75","author":"Van Puyenbroeck","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2023.110871_bb0080","doi-asserted-by":"crossref","first-page":"14516","DOI":"10.1038\/ncomms14516","article-title":"Dissecting the molecular organization of the translocon-associated protein complex","volume":"8","author":"Pfeffer","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity."},{"key":"10.1016\/j.cellsig.2023.110871_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155548","article-title":"Chemokines and the extracellular matrix: set of targets for tumor development and treatment","volume":"144","author":"da Silva","year":"2021","journal-title":"Cytokine."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110871_bb0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2023.110871_bb0100","first-page":"9","article-title":"Cytotoxic T-cells mediate exercise-induced reductions in tumor growth","author":"Rundqvist","year":"2020","journal-title":"Elife."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110871_bb0105","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010056","article-title":"Fine-tuning the tumour microenvironment: current perspectives on the mechanisms of tumour immunosuppression","volume":"10","author":"Armitage","year":"2021","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110871_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001536","article-title":"Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity","volume":"9","author":"Gao","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2023.110871_bb0120","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110871_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2023.110871_bb0130","doi-asserted-by":"crossref","first-page":"1007812","DOI":"10.3389\/fimmu.2022.1007812","article-title":"Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110871_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CNQ.0000000000000117","article-title":"Immunosuppression in solid-organ transplantation: essentials and practical tips","volume":"39","author":"Jasiak","year":"2016","journal-title":"Crit. Care Nurs. Q"},{"issue":"14","key":"10.1016\/j.cellsig.2023.110871_bb0140","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/febs.13656","article-title":"Targeting regulatory T cells in tumors","volume":"283","author":"Liu","year":"2016","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110871_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in Cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110871_bb0150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI37223","article-title":"Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model","volume":"120","author":"Jablonska","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110871_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2023.110871_bb0160","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1172\/JCI82152","article-title":"LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment","volume":"125","author":"Pena","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7525","key":"10.1016\/j.cellsig.2023.110871_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis","volume":"515","author":"Bonapace","year":"2014","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110871_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110871_bb0175","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00262-016-1810-0","article-title":"High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy","volume":"65","author":"Kalathil","year":"2016","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:13:39Z","timestamp":1760267619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823002851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"alternative-id":["S0898656823002851"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110871","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signal sequence receptor subunit 3: A novel indicator of immunosuppressive tumor microenvironment and clinical benefits from immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110871"}}